title: Emergence of macrolide resistance during treatment of pneumococcal pneumonia.
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Musher
authors.forename: Mark E
authors.initials: ME
authors.lastname: Dowell
authors.forename: Virginia D
authors.initials: VD
authors.lastname: Shortridge
authors.forename: Robert K
authors.initials: RK
authors.lastname: Flamm
authors.forename: James H
authors.initials: JH
authors.lastname: Jorgensen
authors.forename: Pierre
authors.initials: P
authors.lastname: Le Magueres
authors.forename: Kurt L
authors.initials: KL
authors.lastname: Krause
mesh_terms: D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D001665:Binding Sites; D004352:Drug Resistance, Microbial; D017809:Fatal Outcome; D006801:Humans; D018942:Macrolides; D009154:Mutation; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*; D020449:Repetitive Sequences, Amino Acid; D013296:Streptococcus pneumoniae / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides